UNLIMITED TURBO SHORT - MODERNA Stock

Certificat

DE000PG1A9N2

Market Closed - Boerse Frankfurt Warrants 03:50:24 2024-07-04 pm EDT
7.84 EUR -3.09% Intraday chart for UNLIMITED TURBO SHORT - MODERNA
Current month-1.26%
1 month+44.90%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-04 7.81 -3.46%
24-07-03 8.09 +0.37%
24-07-02 8.06 -0.74%
24-07-01 8.12 +2.65%
24-06-28 7.91 +3.40%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 03:50 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MODERNA, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PG1A9N
ISINDE000PG1A9N2
Date issued 2024-05-22
Strike 199.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 5.63
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.28
Lowest since issue 3.24

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
116 USD
Average target price
145.9 USD
Spread / Average Target
+25.79%
Consensus